Prognostic value of dual-source multidetector computed tomography coronary angiography in patients with stent

Hamza Sunman1, Hikmet Yorgun, Uğur Canpolat

  • 1Department of Cardiology, Ministry of Health Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey, hamzasunman@gmail.com.

Insights

Dual-source 64-slice multidetector computed tomography (MDCT) effectively predicts outcomes in patients with coronary stents. A patent stent without neointimal hyperplasia (NIH) indicates a good prognosis, while NIH presence signals increased cardiovascular events.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Radiology

Background:

  • Coronary artery disease (CAD) management frequently involves stent implantation.
  • Assessing the long-term patency and prognostic value of coronary stents is crucial for patient outcomes.
  • Dual-source 64-slice multidetector computed tomography (MDCT) offers advanced imaging capabilities for evaluating coronary arteries.

Purpose of the Study:

  • To evaluate the prognostic significance of dual-source 64-slice MDCT in patients with coronary stents.
  • To determine the association between stent patency, neointimal hyperplasia (NIH) presence, and major cardiovascular events (MACEs).
  • To establish MDCT as a reliable tool for post-stenting patient evaluation.

Main Methods:

  • Retrospective analysis of 173 patients with prior stent implantation undergoing dual-source 64-slice MDCT.
  • Evaluation of 213 coronary stents for patency and presence/degree of neointimal hyperplasia (NIH).
  • Follow-up for major cardiovascular events (MACEs) associated with the stented segment over a mean of 21.2 months.

Main Results:

  • Patients with a patent stent and no NIH on MDCT showed a high event-free rate (95.2%) over a 2-year follow-up.
  • The presence of nonobstructive or obstructive NIH was associated with an increased rate of MACEs originating from the stented segment.
  • MDCT accurately identified stent patency and NIH, correlating with clinical outcomes.

Conclusions:

  • Dual-source 64-slice MDCT is a reliable tool for assessing coronary stent patency and neointimal hyperplasia.
  • MDCT findings of a patent stent without NIH predict a favorable prognosis in patients post-stenting.
  • MDCT can guide clinical management by identifying patients at higher risk for cardiovascular events due to stent issues.

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...